InvestorsHub Logo

cyclone101

03/20/10 6:45 PM

#2460 RE: curber #2446

FDA's MAIN concern is lack of people in the study -- and comparable drugs

its new to them as well so they called insufficient -- and extend it for us and them

since then, they have fast track the approval date and approved the plant --- those are good signs -- not bad IMHO